ArticleMedical oncology (Northwood, London, England)2018

Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer.

Hannah Fuchs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.